as of 11-28-2025 12:52pm EST
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | TARRYTOWN |
| Market Cap: | 2.8B | IPO Year: | 2005 |
| Target Price: | $86.40 | AVG Volume (30 days): | 454.8K |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 4.04 | EPS Growth: | -1.41 |
| 52 Week Low/High: | $57.25 - $90.04 | Next Earning Date: | 11-06-2025 |
| Revenue: | $1,110,479,000 | Revenue Growth: | -0.02% |
| Revenue Growth (this year): | -2% | Revenue Growth (next year): | 2.69% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Director
Avg Cost/Share
$59.35
Shares
3,000
Total Value
$178,050.00
Owned After
51,594
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| BYOM JOHN E | PBH | Director | Nov 25, 2025 | Sell | $59.35 | 3,000 | $178,050.00 | 51,594 |
See how PBH stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "PBH Prestige Consumer Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.